Stocks Listing
FOLD

Amicus Therapeutics, Inc.

Share
FOLD
$12.72 3.84%Last Updated Dec 02 2022 08:56 PM
1D Low / 1D High
Low:$12.12
High:$12.72
1D
3.84%
5D
9.66 %
30D
23.86 %
BulletPurple
Market Cap
$3,572,215,552
3.54 %
3.6 B
BulletBlue
Volume 1D
1,477,417
-
1.5 M
BulletOrange
Circulating Supply
280,944,990 FOLD
280.9 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data; gene therapies for Fabry and Pompe diseases, as well as for various types of Batten diseases; enzyme replacement therapies for Pompe diseases; and CDKL5 deficiency disorder product candidates. The company also has additional gene therapies in active preclinical development, including gene therapies for mucopolysaccharidosis type IIIB, as well as a next generation program in mucopolysaccharidosis type IIIA. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Closed
NGM
NASDAQ Stock Exchange
USA
Opens in
11 hours, 45 minutes
Working Hours
Mon-Fri, 02:30 PM - 09:00 PM
Timezone
GMT+0